Dr Anthony Blaise Greer, MD | |
110 Pepper Hill Way, Aiken, SC 29801-2818 | |
(803) 642-6060 | |
(803) 642-0754 |
Full Name | Dr Anthony Blaise Greer |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 14 Years |
Location | 110 Pepper Hill Way, Aiken, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780905737 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0009X | Ophthalmology - Glaucoma Specialist | MD81606 (South Carolina) | Secondary |
207W00000X | Ophthalmology | 2015-00366 (North Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aiken Ophthalmology Pc | 6103885587 | 5 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many chronic disorders arise from misdirected immune responses. A Ludwig-Maximilians-Universitaet in Munich team led by Oliver Söhnlein now shows that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death and that a tailored peptide inhibits the process.
Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame.
A decision issued today by a regional director of the National Labor Relations Board (NLRB) has put at risk the guaranteed raises, healthcare coverage, and pensions of Kaiser Permanente RNs, social workers, and professionals in Southern California.
Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., and Integrated DNA Technologies (IDT) today announced a new collaboration to support targeted RNA sequencing.
› Verified 6 days ago
Entity Name | Aiken Ophthalmology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659315802 PECOS PAC ID: 6103885587 Enrollment ID: O20041011000337 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many chronic disorders arise from misdirected immune responses. A Ludwig-Maximilians-Universitaet in Munich team led by Oliver Söhnlein now shows that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death and that a tailored peptide inhibits the process.
Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame.
A decision issued today by a regional director of the National Labor Relations Board (NLRB) has put at risk the guaranteed raises, healthcare coverage, and pensions of Kaiser Permanente RNs, social workers, and professionals in Southern California.
Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., and Integrated DNA Technologies (IDT) today announced a new collaboration to support targeted RNA sequencing.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Anthony Blaise Greer, MD 110 Pepper Hill Way, Aiken, SC 29801-2818 Ph: (803) 642-6060 | Dr Anthony Blaise Greer, MD 110 Pepper Hill Way, Aiken, SC 29801-2818 Ph: (803) 642-6060 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many chronic disorders arise from misdirected immune responses. A Ludwig-Maximilians-Universitaet in Munich team led by Oliver Söhnlein now shows that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death and that a tailored peptide inhibits the process.
Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame.
A decision issued today by a regional director of the National Labor Relations Board (NLRB) has put at risk the guaranteed raises, healthcare coverage, and pensions of Kaiser Permanente RNs, social workers, and professionals in Southern California.
Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., and Integrated DNA Technologies (IDT) today announced a new collaboration to support targeted RNA sequencing.
› Verified 6 days ago
Richard L. Grantham, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 139 Waterloo St Sw, Aiken, SC 29801 Phone: 803-642-1000 Fax: 803-642-0036 | |
Dr. Kishan Govind, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Pepper Hill Way, Aiken, SC 29801 Phone: 803-642-6060 | |
Dr. Stephen Myles Potter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Pepper Hill Way, Aiken, SC 29801 Phone: 803-642-6060 Fax: 803-642-0754 |